Beta Bionics, Inc. Common Stock (BBNX) is a publicly traded Healthcare sector company. As of September 15, 2026, BBNX trades at $16.46 with a market cap of $745.48M and a P/E ratio of 0.00. BBNX moved -1.61% today. Year to date, BBNX is -45.09%; over the trailing twelve months it is -36.65%. Its 52-week range spans $8.80 to $32.71. Analyst consensus is strong buy with an average price target of $21.43. Rallies surfaces BBNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover BBNX: 0 strong buy, 7 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $21.43.
| Metric | Value |
|---|---|
| Price | $16.46 |
| Market Cap | $745.48M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.71 |
| 52-Week Low | $8.80 |
| Volume | 5.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover BBNX: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.43.